Amyotrophic lateral sclerosis (ALS)

Main navigation

Living with ALS and making a difference

30 Nov 2023

My name is Kris Noakes. As someone living with ALS, I have decided to donate my patient data and biological samples to The Neuro’s C-BIG biobank– the world’s largest biobank for neurological...

Read more about Living with ALS and making a difference

Tiny fish could be the key to an ALS breakthrough

31 May 2022

Gary Armstrong has high praise for zebrafish, a species of fish that he is using to look for new ways to treat ALS, a fatal neurodegenerative disease that has defied a cure and effective treatments.

Read more about Tiny fish could be the key to an ALS breakthrough

New Faculty Spotlight: Sali Farhan

23 Feb 2021

Sali Farhan is an accomplished human genomicist who bridges the gap between the clinic and the lab.

Read more about New Faculty Spotlight: Sali Farhan

A brighter future for ALS patients

1 May 2020

The first drug to be given Health Canada approval for amyotrophic lateral sclerosis (ALS) in more than two decades is now covered by Quebec public health insurance, a major victory for ALS patients...

Read more about A brighter future for ALS patients

The Neuro logo

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.